GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 131 filers reported holding GENOMIC HEALTH INC in Q2 2016. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $251,000 | +1040.9% | 3,694 | +1072.7% | 0.01% | +1000.0% |
| Q1 2019 | $22,000 | 0.0% | 315 | -8.2% | 0.00% | 0.0% |
| Q4 2018 | $22,000 | 0.0% | 343 | +7.2% | 0.00% | 0.0% |
| Q3 2018 | $22,000 | +120.0% | 320 | +60.0% | 0.00% | 0.0% |
| Q2 2018 | $10,000 | +66.7% | 200 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | -84.6% | 200 | -83.3% | 0.00% | -100.0% |
| Q3 2017 | $39,000 | -75.0% | 1,200 | -77.4% | 0.00% | -78.9% |
| Q4 2016 | $156,000 | +254.5% | 5,300 | +251.9% | 0.02% | +280.0% |
| Q3 2016 | $44,000 | -50.0% | 1,506 | -55.8% | 0.01% | -58.3% |
| Q2 2016 | $88,000 | +54.4% | 3,406 | +48.1% | 0.01% | +50.0% |
| Q1 2016 | $57,000 | -18.6% | 2,300 | +4.5% | 0.01% | -20.0% |
| Q4 2014 | $70,000 | -1.4% | 2,200 | -12.0% | 0.01% | 0.0% |
| Q3 2014 | $71,000 | +18.3% | 2,500 | +13.6% | 0.01% | +25.0% |
| Q2 2014 | $60,000 | +3.4% | 2,200 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $58,000 | +107.1% | 2,200 | +144.4% | 0.01% | +60.0% |
| Q3 2013 | $28,000 | – | 900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,668,866 | $353,955,000 | 3.71% |
| Camber Capital Management LP | 2,458,100 | $63,652,000 | 3.08% |
| Ghost Tree Capital, LLC | 200,000 | $5,179,000 | 1.50% |
| Tributary Capital Management, LLC | 206,291 | $5,342,000 | 0.78% |
| Motley Fool Asset Management LLC | 131,935 | $3,416,000 | 0.74% |
| CORRADO ADVISORS, LLC | 40,695 | $1,054,000 | 0.68% |
| Broadfin Capital, LLC | 270,400 | $7,002,000 | 0.68% |
| ACUTA CAPITAL PARTNERS, LLC | 48,800 | $1,264,000 | 0.61% |
| Motley Fool Wealth Management, LLC | 123,018 | $3,186,000 | 0.35% |
| TFS CAPITAL LLC | 61,773 | $1,600,000 | 0.29% |